Related Experiment Video
Updated: Jan 12, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Predicting end-of-life risk in patients with cancer: A multicenter cohort study
Lu Peng1, Yixuan Wang1, Wenzhi Zhao1
1Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Abstract:
ObjectiveManaging end-of-life (EOL) patients with cancer has always been a major challenge in healthcare. Previous studies have highlighted the need for individualized EOL treatment and the importance of avoiding overtreatment. However, accurately identifying EOL patients with cancer to provide appropriate care and improve their quality of life remains an unresolved issue.MethodsThis study was based on investigation on Nutrition Status and Clinical Outcomes of Common Cancer (INSCOC) cohort. Machine-learning methods analyzed the characteristics of EOL patients with cancer and identified the determinants associated with EOL risk. Population-attributable fractions, least absolute shrinkage and selection operator regression analysis, random forest, and logistic regression (LR) analysis were used to screen predictive indicators for EOL risk. LR, support vector machines, generalized linear models, gradient boosting machine, random forests, and artificial neural networks were then used to construct models based on the identified risk factors.ResultsIn total, 17,013 patients from the INSCOC cohort (including 1109 EOL patients) were analyzed. LR was the best-performing machine-learning model, and factors such as advanced stage, neutrophil-to-lymphocyte ratio, malnutrition, hypoalbuminemia, poor self-health assessment, limited mobility, prognostic nutritional index, lack of appetite, and cancer location were the key determinants of EOL risk.ConclusionThe findings of this study provide valuable insights for clinical practice, indicating potential pathways for the more precise management of patients with EOL cancer. Through timely identification and intervention of the identified risk factors, the risk of EOL in these patients may be reduced and their prognosis can be improved.
More Related Videos
Related Concept Videos
Cancer Survival Analysis
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Kaplan-Meier Approach
Actuarial Approach
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Comparing the Survival Analysis of Two or More Groups
Assumptions of Survival Analysis

